期刊文献+

胰腺癌淋巴结转移情况对预后的影响 被引量:14

The influence of lymph node metastasis on prognosis of pancreatic carcinoma
下载PDF
导出
摘要 目的研究淋巴结转移情况对胰腺癌患者预后的影响。方法回顾性分析我院2009年1月至2015年8月72例行根治性手术的胰腺癌患者淋巴结转移情况及其对预后的影响。结果检出淋巴结961枚,平均13.3枚/例;其中阳性淋巴结87枚。单因素分析显示:得到随访的有淋巴结转移者(PN1)33例(47%),中位生存期为8.6个月;得到随访的无淋巴结转移者(PN0)37例(53%),中位生存期18.6个月;无淋巴结转移者生存率显著高于有淋巴结转移患者(P<0.05)。在有淋巴结转移的患者中,淋巴结阳性比率(LNR)>0.2者14例(42%),中位生存期为6.4个月;LNR≤0.2者19例(58%),中位生存期11.4个月;LNR>0.2者生存率显著低于LNR≤0.2者(P<0.05)。淋巴结转移局限于第1站的有17例(52%),中位生存期为11.0个月;第2站以上淋巴结转移者16例(48%),中位生存期7.5个月;第2站以上淋巴结转移者生存率显著低于淋巴结转移局限于第1站者(P<0.05)。多因素分析显示:第2站以上淋巴结转移、淋巴结阳性比率>0.2仍然是影响胰腺癌预后的独立危险因素(P<0.05)。此外,肿瘤侵犯范围、综合治疗、肿瘤分化程度也影响胰腺癌预后(P<0.05)。结论胰腺癌淋巴结转移率较高,LNR>0.2及第2站以上淋巴结转移是影响胰腺癌预后的独立危险因素。 Objective To explore the impact of lymph nodes metastasis on prognosis of pancreatic carcinoma patients. Methods The clinical data of lymph nodes metastasis and clinic outcome of 72 patients with pancreatic caicinoma who underwent radial surgery from Jan. 2009 to Aug. 2015 in our hospital were analyzed retrospectively.Results A total of 961 lymph nodes were detected, 13.3 nodes in one case on average. Among them, 87 lymph nodes were positive, 2.6 nodes in one case on average. Univariate analysis showed that 33 cases who had followup visit were lymph nodes metastasis (PN1, 47.%), in which the median survival was 8.6 mon; 37 cases who had follow-up visit were non-lymph nodes metastasis (PN0, 53.%), in which the median survival was 18.6 mon, and the survival rate with non-lymph nodes metastasis was higher than those with lymph nodes metastasis (P<0.05).Among lymph nodes metastasis patients, lymph nodes positive rate with LNR >0.2 was 14 cases (42%), in which the median survival was 6.4 mon; lymph nodes positive rate with LNR≤0.2 was 19 cases (58%), in which the median survival was 11.4 mon; and the survival rate with LNR>0.2 was significant lower than that with LNR≤0.2 (P<0.05). Lymph nodes metastasis which was limited in the first period were 17 cases (52%), the median survival metastasis was 11.0 mon; the lymph nodes metastasis beyond the first period were 16 cases (48%), the median survival metastasis was 7.5 mon; and the survival rate beyond the first period was significant lower than that within the first period (P<0.05). Multivariate analysis showed that lymph nodes metastasis beyond the first period, lymph nodes positive rate with LNR>0.2 were independent risk factors affecting the prognosis in pancreatic cancer patients (P<0.05). Besides, tumor invasion range, composite curing, the degree of tumor differentiation all affected the prognosis. Conclusion The rate of lymph nodes metastasis is high. Lymph nodes metastasis beyond the first period and LNR>0.2 are independent risk factors affecting the prognosis in pancreatic cancer patients.
作者 方向 麦刚 刘忠亮 安亮 杨勇 贺俊文 FANG Xiang;MAI Gang;LIU Zhong-liang;AN Liang;YANG Yong;HE Jun-wen(Department of Hepatobiliary and Pancreatic Surgery, the People’s Hospital of Deyang, Deyang, Sichuan 618000, China)
出处 《肝胆胰外科杂志》 CAS 2017年第1期27-31,共5页 Journal of Hepatopancreatobiliary Surgery
关键词 胰腺癌 淋巴结转移 根治性手术 预后 pancreatic caicinoma lymph nodes metastasis radial surgery prognosis
  • 相关文献

参考文献8

二级参考文献114

  • 1倪泉兴,傅德良,蒋永剑,张群华,姚琪远,虞先浚,张延龄.胰头癌淋巴转移特点的探索和影响的因素[J].中华肝胆外科杂志,2004,10(4):231-234. 被引量:20
  • 2倪泉兴.胰腺癌的临床流行病学研究现况[J].胰腺病学,2006,6(2):65-68. 被引量:6
  • 3Emre F Yekebas,Dean Bogoevski,Michael Bubenheim,Bjrn-Christian Link,Jussuf T Kaifi,Robin Wachowiak,Oliver Mann,Asad Kutup,Guellue Cataldegirmen,Lars Wolfram,Andreas Erbersdobler,Christoph Klein,Klaus Pantel,Jakob R Izbicki.Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy[J].World Journal of Gastroenterology,2006,12(40):6515-6521. 被引量:3
  • 4Neoptolemos J P,Stoeken DD, Friess H, el al. A randomized trial of chemoradiotherapy and chemotherapy after reseclion of panereatie eancer [J ]. N Engl J Med,2004,350( 12): 1200-1210.
  • 5Oettle H, Post S, Neuhaus P, et al. Adjuvanl chemotherapy with gemcitabine vs observation in patients undergoing cnralive-intent resection of pancreatic cancer: a randomized controlled trial [ J ]. J AM A, 2007,297(3):267-277.
  • 6Karanieolas PJ, Davies E, Kunz R, et al. The pylorus: lake it or leave it? Systematic review and mela-analysis of pylorus-preserving versus standard Whipple panereaticoduodeneetotiay for panereatie or periampullary eaneer [J]. Ann Surg Oneol, 2007, 14(6):1825-1834.
  • 7Diener MK, Knaebel HP, Heukaufer C, et al. A syslemalic review and melaanalysis of pylorus-preserving versus elassical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma [J]. Ann Surg, 2007, 245(2): 187-200.
  • 8Verbeke CS, Leitch D, Menon KV, et al. Redefining the R1 resection in pancreatic cancer [J]. Br J Surg, 2006, 93(10): 1232-1237.
  • 9Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are RI resections [J]. Ann Surg Oncol,2008,15(6): 1651-1660.
  • 10Jamieson NB, Foulis AK, Oien KA, et al. Positive mobilization margins alone do not influence survival following pancreatic ductal adenoca rcinoma [ J ]. Ann Surg, 2010,251 (6) : 1003 - 1010.

共引文献36

同被引文献122

引证文献14

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部